Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study

Published:2019-05 Issue:11 Volume:120 Page:1026-1032
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Blay Jean-Yves,Schöffski Patrick,Bauer Sebastian,Krarup-Hansen Anders,Benson Charlotte,D’Adamo David R.,Jia Yan,Maki Robert G.

Funder

This work was supported by Eisai Inc., Woodcliff Lake, NJ

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-019-0462-1.pdf

Reference29 articles.

1. Mastrangelo, G., Coindre, J. M., Ducimetière, F., Dei Tos, A. P., Fadda, E. Blay, J. Y. et al. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. Cancer 118, 5339–5348 (2012).

2. Stiller, C. A., Trama, A., Serraino, D., Rossi, S., Navarro, C., Chirlaque, M. D. et al. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur. J. Cancer 49, 684–695 (2013).

3. Ferrari, A., Sultan, I., Huang, T. T., Rodriguez-Galindo, C., Shehadeh, A, Meazza, C. et al. Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database. Pedia. Blood Cancer 57, 943–949 (2011).

4. Toro, J. R., Travis, L. B., Wu, H. J., Zhu, K., Fletcher, C. D. & Devesa, S. S. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases. Int. J. Cancer 119, 2922–2930 (2006).

5. Zagars, G. K., Ballo, M. T., Pisters, P. W., Pollock, R. E., Patel, S. R. & Benjamin, R. S. Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 57, 739–747 (2003).

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: A systematic review;Critical Reviews in Oncology/Hematology;2024-05

2. Uterine leiomyosarcoma cell-derived extracellular vesicles induce the formation of cancer-associated fibroblasts;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-04

3. Pharmacokinetics of dacarbazine and unesbulin and CYP1A2‐mediated drug interactions in patients with leiomyosarcoma;Clinical and Translational Science;2024-01-30

4. Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates;Clinical Cancer Research;2024-01-18

5. Chemotherapy With Eribulin Following Potentially Curative Surgery in Patients With Localized Liposarcoma;In Vivo;2023-12-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3